Skip Navigation

A Phase II, Open-label, Multicenter Study of IBI363 PD1-IL2m in Subjects with Advanced Solid Malignancies

Brief Summary

Type:
Other

Study Type:
Treatment

Phase:
II

ClinicalTrials.gov Identifier:
NCT06281678

Study #:
STUDY00160463

Start Date:
Sep 11, 2024

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT06281678

View Complete Trial Details & Eligibility at ClinicalTrials.gov